Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 15 of 25

  1. A total of 2,818 patients diagnosed with MCOA were identified, and the 5-year survival rate was 62%. Univariate and multivariate Cox models suggested that age (HR=1.28, 95% CI[1.15,1.44]), grade (HR=1.26, 95% CI[...

    Authors: Huijie Wu, Shaotao Jiang, Peiwen Zhong, Weiru Li and Siyou Zhang
    Citation: Journal of Ovarian Research 2021 14:137
    Content type: Research Published on:

  2. Clinical trials are currently exploring combinations of PARP inhibitors and immunotherapies for the treatment of ovarian cancer, but their effects on the ovarian tumour...BRCA deficiencies can influence the respo...

    Authors: Salar Farokhi Boroujeni, Galaxia Rodriguez, Kristianne Galpin, Edward Yakubovich, Humaira Murshed, Dalia Ibrahim, Sara Asif and Barbara C. Vanderhyden
    Citation: Journal of Ovarian Research 2023 16:231
    Content type: Research Published on:

  3. The epithelial-mesenchymal transition (EMT) promotes cell signaling and morphology alterations, contributing to cancer progression. Exosomes, extracellular vesicles containing proteins...

    Authors: Germano Aguiar Ferreira, Carolina Hassibe Thomé, Clarice Izumi, Mariana Lopes Grassi, Guilherme Pauperio Lanfredi, Marcus Smolka, Vitor Marcel Faça and Francisco José Candido dos Reis
    Citation: Journal of Ovarian Research 2023 16:232
    Content type: Research Published on:

  4. We showed there are specific ALDH1 autoantibodies in ovarian autoimmune disease and ovarian cancer, suggesting a role for ALDH1 in ovarian ... determine if ALDH1 expression is altered in ovarian cancer. Since the...

    Authors: Krishna Penumatsa, Seby L Edassery, Animesh Barua, Michael J Bradaric and Judith L Luborsky
    Citation: Journal of Ovarian Research 2010 3:28
    Content type: Research Published on:

  5. Histological analysis has revealed the need for new treatment techniques for epithelial ovarian cancer. Immune checkpoint inhibitors may be a new...

    Authors: Sumika Zaitsu, Mitsutake Yano, Sawako Adachi, Maiko Miwa, Tomomi Katoh, Yasushi Kawano and Masanori Yasuda
    Citation: Journal of Ovarian Research 2023 16:93
    Content type: Research Published on:

  6. Epithelial Ovarian Cancer (EOC) is the second most common gynaecological cancer and accounts for more deaths than all gynaecological cancers combined. Despite extensive research, progress has ... profiling. Cell ...

    Authors: Thumuluru Kavitha Madhuri, Anil Tailor, Ben Haagsma, Helen Coley and Simon Butler-Manuel
    Citation: Journal of Ovarian Research 2012 5:46
    Content type: Review Published on:

  7. After the introduction of pre-admission screening, RT-PCR and CT were performed in 200 and 76 patients, respectively, as of June 30, 2020. The treatment of five patients, including two patients with cervical cancer

    Authors: Yuya Nogami, Yusuke Kobayashi, Kosuke Tsuji, Megumi Yokota, Hiroshi Nishio, Masaru Nakamura, Wataru Yamagami, Tohru Morisada, Eiichiro Tominaga, Kouji Banno and Daisuke Aoki
    Citation: Journal of Ovarian Research 2020 13:105
    Content type: Case report Published on:

  9. Follicle stimulating hormone (FSH) is secreted by the anterior pituitary and acts on the germ cells indirectly through Granulosa cells in ovaries and Sertoli cells in the testes. Extragonadal action of FSH has be...

    Authors: Deepa Bhartiya, Hiren Patel, Ankita Kaushik, Pushpa Singh and Diksha Sharma
    Citation: Journal of Ovarian Research 2021 14:145
    Content type: Review Published on:

    The Commentary to this article has been published in Journal of Ovarian Research 2021 14:146

    The Review to this article has been published in Journal of Ovarian Research 2021 14:144

  10. Serous ovarian carcinomas (SCA) are the most common and most aggressive ovarian carcinoma subtype which etiology remains unclear. To investigate the prospective role of mRNAs in the tumorigenesis and progressi...

    Authors: Hongjun Fei, Songchang Chen and Chenming Xu
    Citation: Journal of Ovarian Research 2020 13:82
    Content type: Research Published on:

  11. Ovarian cancer is sixth most common cancer among women and the leading cause of ... gynecological malignancies. Despite the great impact ovarian cancer has on women's health and its...

    Authors: Marcela F Paes, Renata D Daltoé, Klesia P Madeira, Lucas CD Rezende, Gabriela M Sirtoli, Alice L Herlinger, Leticia S Souza, Luciana B Coitinho, Débora Silva, Murilo F Cerri, Ana Cristina N Chiaradia, Alex A Carvalho, Ian V Silva and Leticia BA Rangel
    Citation: Journal of Ovarian Research 2011 4:14
    Content type: Research Published on:

  13. We performed data analysis from 19,276 patients identified from the SEER database of the National Cancer Center of the United States. 57.8 ... analysis showed that the patients with serous ovarian cancer in the u...

    Authors: Pei Luo, Jian-Guo Zhou, Su-Han Jin, Ming-Song Qing and Hu Ma
    Citation: Journal of Ovarian Research 2019 12:126
    Content type: Research Published on:

  14. The purpose of this study is to identify a prospective association between CA125 and tumorigenic ovarian cancer cells, using the new method of orthotopic...

    Authors: Hui Zhang, Yongan Yang, Yifeng Wang, Xinping Gao, Weiming Wang, Hui Liu, Haipeng He, Yijuan Liang, Kun Pan, Hongli Wu, Junrong Shi, Huiling Xue, Ling Liang, Zhihuci Cai, Yanfang Fan and Yanyan Zhang
    Citation: Journal of Ovarian Research 2015 8:19
    Content type: Research Published on:

  15. The aim of this study was to evaluate HE4, CA125 and ROMA in the preoperative differentiation benign ovarian diseases from epithelial ovarian cancer depending on the menopausal status.

    Authors: Katarzyna M. Terlikowska, Bozena Dobrzycka, Anna M. Witkowska, Beata Mackowiak-Matejczyk, Tomasz Kamil Sledziewski, Maciej Kinalski and Slawomir J. Terlikowski
    Citation: Journal of Ovarian Research 2016 9:43
    Content type: Research Published on:

  17. Oxidative damage and DNA repair dysfunction are associated with carcinogenesis. 8-OHdG is one of the major oxidative DNA adducts. Present work aims to investigate whether the expression of 8-OHdG and its key r...

    Authors: Xia Xu, Yan Wang, Wenwen Guo, Yiqing Zhou, Chunmei Lv, Xiaoxiang Chen and Kaijiang Liu
    Citation: Journal of Ovarian Research 2013 6:74
    Content type: Research Published on:

  18. A total of 708 PPSC patients and 7610 ASOC patients were enrolled. The clinical features of PPSC patients were noticeably different from those of ASOC patients. The survival analysis showed that PPSC patients had...

    Authors: Xiaoduo Li, Qiao Yang, Mingjing Chen, Changqing Yang, Jianfen Gu, Qiang Dong and Guangrong Yang
    Citation: Journal of Ovarian Research 2021 14:40
    Content type: Research Published on:

  19. This was a single oncology centre, retrospective diagnostic accuracy study of 620 patients. All patients underwent surgery, and the histopathological diagnosis was used as a reference standard. The masses were di...

    Authors: Ping He, Jing-jing Wang, Wei Duan, Chao Song, Yu Yang and Qing-qing Wu
    Citation: Journal of Ovarian Research 2021 14:169
    Content type: Research Published on:

  24. Herein, we explored the relationship between tumour microenvironment (TME) reprogramming and tissue invasion based on single-cell RNA sequencing (scRNA-seq) datasets. Interestingly, hypoxia, oxidative phosphoryla...

    Authors: Yuanfu Zhang, Shu Sun, Yue Qi, Yifan Dai, Yangyang Hao, Mengyu Xin, Rongji Xu, Hongyan Chen, Xiaoting Wu, Qian Liu, Congcong Kong, Guangmei Zhang, Peng Wang and Qiuyan Guo
    Citation: Journal of Ovarian Research 2023 16:200
    Content type: Research Published on:

  26. Standard platinum-based therapy for ovarian cancer is inefficient against ovarian clear cell carcinoma ... OCCC is a distinct subtype of epithelial ovarian cancer. OCCC constitutes 25% of ovarian cancers in East ...

    Authors: Wenwen Chien, Jeffrey W. Tyner, Sigal Gery, Yueyuan Zheng, Li-Yan Li, Mohan Shankar Gopinatha Pillai, Chehyun Nam, Neil A. Bhowmick, De-Chen Lin and H. Phillip Koeffler
    Citation: Journal of Ovarian Research 2023 16:80
    Content type: Research Published on:

  27. Investigate the impact of interval cytoreductive surgery (ICS) on progression in an orthotopic mouse model of ovarian cancer and the impact of chemotherapy delivered at...

    Authors: Mitchell Clark, Alexandra Kollara, Theodore J. Brown and Taymaa May
    Citation: Journal of Ovarian Research 2021 14:157
    Content type: Research Published on:

  28. There are well-known side effects of chemotherapy and radiotherapy that are mainly related to the toxicity and impaired function of vital organs; however, the induction by these therapies of expression of seve...

    Authors: Mariusz Z Ratajczak, Tomasz Jadczyk, Gabriela Schneider, Sham S Kakar and Magda Kucia
    Citation: Journal of Ovarian Research 2013 6:95
    Content type: Research Published on:

  29. Investigating the utility of serum exosomal markers CA125, HE4, and C5a, both individually and in combination, for distinguishing between benign and malignant ovarian tumors.

    Authors: Huihui Shi, Liya Liu, Xueli Deng, Xiaoyu Xing, Yan Zhang, Yemeli Djouda Rebecca and Liping Han
    Citation: Journal of Ovarian Research 2024 17:4
    Content type: Research Published on:

  30. Homologous Recombination Deficiency (HRD) is a predictive biomarker for ovarian cancer treated with PARP inhibitors or for breast cancer treated with first-line platinum-based chemotherapy. ... prediction with HR...

    Authors: Zheng Feng, Di Shao, Yuhang Cai, Rui Bi, Xingzhu Ju, Dongju Chen, Chengcheng Song, Xiaojun Chen, Jin Li, Na An, Yunjin Li, Qing Zhou, Zhihui Xiu, Shida Zhu, Xiaohua Wu and Hao Wen
    Citation: Journal of Ovarian Research 2023 16:53
    Content type: Research Published on:

  32. The incidence of intraepithelial neoplasia in the fallopian tubes of high-risk patients at the Aguascalientes Women’s Hospital is 2.4%. Prophylactic salpingectomy is a simple procedure and has the potential to de...

    Authors: Antonio Gabriel Briseño Campos, Antonio Cruz Rodríguez, Martha Olivia García Perales, Francisco Javier Serna Vela, Diana Gabriela Camarillo Elizalde and María del Consuelo Robles Martínez
    Citation: Journal of Ovarian Research 2019 12:54
    Content type: Research Published on:

  34. The inhibition of two major anti-apoptotic proteins, Bcl-xL...and Mcl-1, appears essential to destroy chemoresistant cancer cells. We have studied their concomitant inhibition...

    Authors: Hubert Lincet, Perrine Kafara, Florence Giffard, Edwige Abeilard-Lemoisson, Maryline Duval, Marie-Hélène Louis, Laurent Poulain and Philippe Icard
    Citation: Journal of Ovarian Research 2013 6:72
    Content type: Brief communication Published on:

  35. Although immune system plays a key role in the pathogenesis of both endometriosis and ovarian cancer, its function is different. Therefore, we ... with serous ovarian cysts, endometriosis, and ovarian cancer, whi...

    Authors: Olimpia Sipak-Szmigiel, Piotr Włodarski, Elżbieta Ronin-Walknowska, Andrzej Niedzielski, Beata Karakiewicz, Sylwia Słuczanowska-Głąbowska, Maria Laszczyńska and Witold Malinowski
    Citation: Journal of Ovarian Research 2017 10:25
    Content type: Case report Published on:

  36. Platinum drugs, including cisplatin, are a frontline therapeutic in ovarian cancer treatment and acquired resistance to these agents is a major contributor to ovarian cancer morbidity and mortality. In this study...

    Authors: Matthew J Schultz, Amanda F Swindall, John W Wright, Elizabeth S Sztul, Charles N Landen and Susan L Bellis
    Citation: Journal of Ovarian Research 2013 6:25
    Content type: Research Published on:

  37. ...microRNAs (miRNAs) stably exist in circulating blood encapsulated in extracellular vesicles such as exosomes; therefore, serum miRNAs have the potential to serve as novel cancer biomarkers. New diagnostic mark...

    Authors: Masaki Kobayashi, Kenjiro Sawada, Koji Nakamura, Akihiko Yoshimura, Mayuko Miyamoto, Aasa Shimizu, Kyoso Ishida, Erika Nakatsuka, Michiko Kodama, Kae Hashimoto, Seiji Mabuchi and Tadashi Kimura
    Citation: Journal of Ovarian Research 2018 11:81
    Content type: Research Published on:

  39. There is an urgent need to identify potential targets in anticancer therapy to improve the survival and prognosis of patients with ovarian cancer (OC). Herein, we investigated the...

    Authors: Li-Na Gao, Man Hao, Xiao-Hui Liu, Li Zhang, Yan Dong, Yu-Fang Zhang and Xiao-Chun He
    Citation: Journal of Ovarian Research 2021 14:159
    Content type: Research Published on:

  41. Among 155 patients with adnexal masses meeting inclusion criteria, 120 (77.4%) were benign, 8 (5.2%) borderline and 27 (17.4%) were malignant. RMI2 and RMI4 had the highest sensitivity (66.7%) while HE4 had the h...

    Authors: Abha Hada, Li-ping Han, Yanyan Chen, Qing-hong Hu, Yidan Yuan and Liya Liu
    Citation: Journal of Ovarian Research 2020 13:46
    Content type: Research Published on:

  42. Six women who were diagnosed with ovarian cancer were included in the cancer group, and ten women who were diagnosed ... compare the differences in the bacteria between ovarian cancer tissues and noncancerous ova...

    Authors: Qi Wang, Lanbo Zhao, Lu Han, Guoxing Fu, Xiaoqian Tuo, Sijia Ma, Qing Li, Yiran Wang, Dongxin Liang, Miaomiao Tang, Chao Sun, Qing Wang, Qing Song and Qiling Li
    Citation: Journal of Ovarian Research 2020 13:8
    Content type: Research Published on:

  43. Amplified centrosomes are widely recognized as a hallmark of cancer. Although supernumerary centrosomes would be expected to ... spindles that results in death-inducing aneuploidy, cancer cells suppress multipola...

    Authors: Karuna Mittal, Da Hoon Choi, Sergey Klimov, Shrikant Pawar, Ramneet Kaur, Anirban K. Mitra, Meenakshi V. Gupta, Ralph Sams, Guilherme Cantuaria, Padmashree C. G. Rida and Ritu Aneja
    Citation: Journal of Ovarian Research 2016 9:17
    Content type: Research Published on:

  44. To address a potential link between VSELs and germ line cells we analyzed by RT-PCR and FACS expression of erythropoietin receptor (EpoR) on murine bone marrow- and human umbilical cord blood-derived VSELs, murin...

    Authors: Malwina Suszynska, Agata Poniewierska-Baran, Pranesh Gunjal, Janina Ratajczak, Krzysztof Marycz, Sham S Kakar, Magda Kucia and Mariusz Z Ratajczak
    Citation: Journal of Ovarian Research 2014 7:66
    Content type: Research Published on:

  45. Current protocols for the treatment of ovarian cancer include combination chemotherapy with a platinating agent ... However, many patients experience relapse of their cancer and the development of drug resistance...

    Authors: Stephen R Armstrong, Rashmi Narendrula, Baoqing Guo, Amadeo M Parissenti, Katherine L McCallum, Stephanie Cull and Carita Lannér
    Citation: Journal of Ovarian Research 2012 5:40
    Content type: Research Published on:

  47. Patients treated with neoadjuvant chemotherapy (NACT) for advanced high-grade serous ovarian carcinoma (HGSC) have a higher rate and shorter time to platinum-resistant recurrence compared to patients treated w...

    Authors: Zibi Marchocki, Alicia Tone, Carl Virtanen, Richard de Borja, Blaise Clarke, Theodore Brown and Taymaa May
    Citation: Journal of Ovarian Research 2022 15:50
    Content type: Research Published on:

  48. To determine reference intervals for serum levels of human epididymis protein 4 (HE4) in Chinese women.

    Authors: Yaping Tian, Chuanxin Wang, Liming Cheng, Aimin Zhang, Wen Liu, Lin Guo, Huiming Ye, Yanchun Huang, Jing Chen, Xinyu Wen, Yuelei Xing, Guixi Zheng, Ziyong Sun, Huijun Li, Peng Zhang, Wanli Liu…
    Citation: Journal of Ovarian Research 2015 8:72
    Content type: Research Published on:

  50. We describe a 55-year-old woman diagnosed with stage IB primary ovarian signet-ring cell carcinoma that was treated with S-1/CDDP therapy. Preoperative transvaginal ultrasonography and contrast-enhanced computed ...

    Authors: Tadahiro Shoji, Ryosuke Takeshita, Tatsunori Saito, Takeshi Aida, Shunichi Sasou and Tsukasa Baba
    Citation: Journal of Ovarian Research 2020 13:33
    Content type: Case report Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.

Journal of Ovarian Research

ISSN: 1757-2215

Contact us